Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
The University of Osaka · Fujita Health University
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
718
total citations
- FWCI
- 36.75
- Percentile
- 100%
- References
- 24
Citations per year
Authors
18Topics & keywords
Topics
Keywords
- Epidermal growth factor
- Transactivation
- Muscle hypertrophy
- Heparin-binding EGF-like growth factor
- Metalloproteinase
- Internal medicine
- Endocrinology
- Disintegrin
No related works found for this paper.